Research Article | | Peer-Reviewed

Detection of Carbapenemase Genes in Carbapenemase-producing Klebsiella pneumoniae Isolated from Tay Nguyen Regional General Hospital, Vietnam

Received: 13 October 2025     Accepted: 5 December 2025     Published: 29 December 2025
Views:       Downloads:
Abstract

Background: Carbapenemase-producing Klebsiella pneumoniae (CPKP) has emerged as a major global concern due to extensive antimicrobial resistance, limited therapeutic options, and significant mortality rates. This study aimed to characterize the molecular mechanisms of carbapenem resistance and assess the antibiotic susceptibility patterns of CPKP isolates collected from Tay Nguyen Regional General Hospital, Vietnam. Methods: Seventy-nine non-duplicate K. pneumoniae isolates resistant to at least one carbapenem were analyzed using the modified carbapenem inactivation method (mCIM) and real-time PCR to detect blaKPC, blaNDM, blaVIM and blaOXA-48-like genes. Antimicrobial susceptibility was tested using the disk diffusion method following CLSI 2023 guidelines. Results: Among the 79 isolates, 62 (78.5%) were carbapenemase producers. The most prevalent carbapenemase gene was blaNDM (65.6%), followed by blaOXA-48-like (48.4%), blaKPC (35.9%) and blaVIM (32.8%). Co-harboring of multiple genes was common blaNDM+OXA-48-like (29.7%), blaKPC+NDM (21.9%). Resistance rates exceeded 90% for β-lactams, cephalosporins and quinolones, while all isolates remained susceptible to colistin. Conclusions: The predominance of blaNDM and blaOXA-48-like genes highlights the evolving resistance landscape in Vietnam. Strengthening molecular surveillance, infection control and rational antibiotic use is essential to prevent the spread of multidrug-resistant pathogens.

Published in International Journal of Biomedical Engineering and Clinical Science (Volume 11, Issue 4)
DOI 10.11648/j.ijbecs.20251104.13
Page(s) 73-79
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Carbapenemase, Antibiotic Resistance, Klebsiella pneumoniae, Resistance Genes

References
[1] Centers for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States, 2019. CDC; 2019.
[2] Navon-Venezia S, Kontopoulou K, Nitzan O, et al. Klebsiella pneumoniae: A Major Player in the Field of Antimicrobial Resistance. Frontiers in Microbiology. 2020; 11: 254.
[3] Bush K. The ABCD’s of beta-Lactamase Nomenclature. J Infect Chemother. 2013; 19(4): 549-559.
[4] Tooke CL, Hinchliffe P, Fathima A, et al. Metallo-beta-Lactamases: A New Focus for beta-Lactamase Inhibition. ACS Infect Dis. 2018; 4(9): 1227-1234.
[5] Queenan AM, Bush K. Carbapenemases: The Versatile beta-Lactamases. Clin Microbiol Rev. 2007; 20(3): 440-458.
[6] Yong D, Toleman MA, Giske CG, et al. Characterization of a New Metallo-beta-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrob Agents Chemother. 2009; 53(12): 5046-5054.
[7] Poirel L, Heritier C, Tolun V, et al. Emergence of the Carbapenem-Hydrolyzing Oxacillinase OXA-48 in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004; 48(1): 15-22.
[8] World Health Organization (WHO). Antimicrobial resistance: Global report on surveillance 2014. WHO; 2014.
[9] Van KL, Do TT, Nguyen NT, et al. Molecular Epidemiology and Antimicrobial Resistance of Carbapenem-Resistant Enterobacteriaceae in Vietnam. J Glob Antimicrob Resist. 2021; 24: 14-20.
[10] Tamma PD, Aitken SL, Bonomo RA, et al. Infectious Diseases Society of America Guidance on the Treatment of AmpC beta-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Enterobacterales, and Pseudomonas aeruginosa with Difficult-to-Treat Resistance in Adults. Clin Infect Dis. 2023; 77(6): 835-849.
[11] CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. Wayne, PA: CLSI; 2023.
[12] Tsai, Ya-Min & Wang, Shining & Chiu, Hui-Chuan & Kao, Cheng-Yen & Wen, Li-Li. (2020). Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae. BMC Microbiology. 20.
[13] Doyle, D., et al. Laboratory detection of Enterobacteriaceae that produce carbapenemases. Journal of clinical microbiology, 2012. 50(12): p. 3877-3880.
[14] Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae. Nat Rev Microbiol. 2017.
[15] Van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017.
[16] Pitout JDD, Peirano G, Kock MM. Global expansion of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2020.
[17] Patel G, Bonomo RA. Stormy waters ahead: global emergence of carbapenemases. Front Microbiol. 2013.
[18] Tran HN et al. Molecular epidemiology of carbapenemase genes in Vietnam. J Glob Antimicrob Resist. 2020.
[19] Vu TV et al. Carbapenem-resistant Enterobacterales in Vietnam: an emerging threat. Infect Drug Resist. 2022.
[20] Nguyen KV et al. Genomic insights into multidrug-resistant K. pneumoniae in Vietnam. Microb Genom. 2021.
[21] Dao TT et al. First report of KPC-producing K. pneumoniae in Vietnam. Antimicrob Agents Chemother. 2018.
[22] Thien Phu Truong, Trong Tin Tran, Phuong Mai Le et al. Carbapenemase Genotypes in Carbapenem-Resistant Enterobacterales (CRE) from Clinical Isolates in Southern Vietnam (2023): A Whole Genome Sequencing Analysis, 17 March 2025, PREPRINT (Version 1) available at Research Square
[23] Phu VD et al. Carbapenem resistance mechanisms among Enterobacterales in Hanoi. Clin Infect Dis. 2019.
[24] Sundaramoorthy NS et al. OXA-48-like carbapenemases in Southeast Asia. J Med Microbiol. 2022.
[25] Kumarasamy KK et al. Emergence of NDM-producing Enterobacteriaceae. Lancet Infect Dis. 2010.
[26] Yong D et al. Characterization of blaNDM plasmids globally. Antimicrob Agents Chemother. 2018.
[27] Shen Z et al. Coexistence of multiple carbapenemase genes in CRKP in China. Diagn Microbiol Infect Dis. 2020.
[28] Nordmann P et al. Global spread of carbapenemase producers. Emerg Infect Dis. 2011.
[29] Wang Y et al. Emergence of mcr-mediated colistin resistance. Lancet Infect Dis. 2016.
[30] Shakti L, Veeraraghavan B. Nitrofurantoin susceptibility. Indian J Med Microbiol. 2015; 33 Suppl: S112–S120.
Cite This Article
  • APA Style

    Nie, H. N., Thuy, L. K., Loan, N. T. K., Tuoi, N. H. (2025). Detection of Carbapenemase Genes in Carbapenemase-producing Klebsiella pneumoniae Isolated from Tay Nguyen Regional General Hospital, Vietnam. International Journal of Biomedical Engineering and Clinical Science, 11(4), 73-79. https://doi.org/10.11648/j.ijbecs.20251104.13

    Copy | Download

    ACS Style

    Nie, H. N.; Thuy, L. K.; Loan, N. T. K.; Tuoi, N. H. Detection of Carbapenemase Genes in Carbapenemase-producing Klebsiella pneumoniae Isolated from Tay Nguyen Regional General Hospital, Vietnam. Int. J. Biomed. Eng. Clin. Sci. 2025, 11(4), 73-79. doi: 10.11648/j.ijbecs.20251104.13

    Copy | Download

    AMA Style

    Nie HN, Thuy LK, Loan NTK, Tuoi NH. Detection of Carbapenemase Genes in Carbapenemase-producing Klebsiella pneumoniae Isolated from Tay Nguyen Regional General Hospital, Vietnam. Int J Biomed Eng Clin Sci. 2025;11(4):73-79. doi: 10.11648/j.ijbecs.20251104.13

    Copy | Download

  • @article{10.11648/j.ijbecs.20251104.13,
      author = {H Nuong Nie and Le Ka Thuy and Nguyen Thi Kim Loan and Nguyen Hong Tuoi},
      title = {Detection of Carbapenemase Genes in Carbapenemase-producing Klebsiella pneumoniae Isolated from Tay Nguyen Regional General Hospital, Vietnam},
      journal = {International Journal of Biomedical Engineering and Clinical Science},
      volume = {11},
      number = {4},
      pages = {73-79},
      doi = {10.11648/j.ijbecs.20251104.13},
      url = {https://doi.org/10.11648/j.ijbecs.20251104.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijbecs.20251104.13},
      abstract = {Background: Carbapenemase-producing Klebsiella pneumoniae (CPKP) has emerged as a major global concern due to extensive antimicrobial resistance, limited therapeutic options, and significant mortality rates. This study aimed to characterize the molecular mechanisms of carbapenem resistance and assess the antibiotic susceptibility patterns of CPKP isolates collected from Tay Nguyen Regional General Hospital, Vietnam. Methods: Seventy-nine non-duplicate K. pneumoniae isolates resistant to at least one carbapenem were analyzed using the modified carbapenem inactivation method (mCIM) and real-time PCR to detect blaKPC, blaNDM, blaVIM and blaOXA-48-like genes. Antimicrobial susceptibility was tested using the disk diffusion method following CLSI 2023 guidelines. Results: Among the 79 isolates, 62 (78.5%) were carbapenemase producers. The most prevalent carbapenemase gene was blaNDM (65.6%), followed by blaOXA-48-like (48.4%), blaKPC (35.9%) and blaVIM (32.8%). Co-harboring of multiple genes was common blaNDM+OXA-48-like (29.7%), blaKPC+NDM (21.9%). Resistance rates exceeded 90% for β-lactams, cephalosporins and quinolones, while all isolates remained susceptible to colistin. Conclusions: The predominance of blaNDM and blaOXA-48-like genes highlights the evolving resistance landscape in Vietnam. Strengthening molecular surveillance, infection control and rational antibiotic use is essential to prevent the spread of multidrug-resistant pathogens.},
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Detection of Carbapenemase Genes in Carbapenemase-producing Klebsiella pneumoniae Isolated from Tay Nguyen Regional General Hospital, Vietnam
    AU  - H Nuong Nie
    AU  - Le Ka Thuy
    AU  - Nguyen Thi Kim Loan
    AU  - Nguyen Hong Tuoi
    Y1  - 2025/12/29
    PY  - 2025
    N1  - https://doi.org/10.11648/j.ijbecs.20251104.13
    DO  - 10.11648/j.ijbecs.20251104.13
    T2  - International Journal of Biomedical Engineering and Clinical Science
    JF  - International Journal of Biomedical Engineering and Clinical Science
    JO  - International Journal of Biomedical Engineering and Clinical Science
    SP  - 73
    EP  - 79
    PB  - Science Publishing Group
    SN  - 2472-1301
    UR  - https://doi.org/10.11648/j.ijbecs.20251104.13
    AB  - Background: Carbapenemase-producing Klebsiella pneumoniae (CPKP) has emerged as a major global concern due to extensive antimicrobial resistance, limited therapeutic options, and significant mortality rates. This study aimed to characterize the molecular mechanisms of carbapenem resistance and assess the antibiotic susceptibility patterns of CPKP isolates collected from Tay Nguyen Regional General Hospital, Vietnam. Methods: Seventy-nine non-duplicate K. pneumoniae isolates resistant to at least one carbapenem were analyzed using the modified carbapenem inactivation method (mCIM) and real-time PCR to detect blaKPC, blaNDM, blaVIM and blaOXA-48-like genes. Antimicrobial susceptibility was tested using the disk diffusion method following CLSI 2023 guidelines. Results: Among the 79 isolates, 62 (78.5%) were carbapenemase producers. The most prevalent carbapenemase gene was blaNDM (65.6%), followed by blaOXA-48-like (48.4%), blaKPC (35.9%) and blaVIM (32.8%). Co-harboring of multiple genes was common blaNDM+OXA-48-like (29.7%), blaKPC+NDM (21.9%). Resistance rates exceeded 90% for β-lactams, cephalosporins and quinolones, while all isolates remained susceptible to colistin. Conclusions: The predominance of blaNDM and blaOXA-48-like genes highlights the evolving resistance landscape in Vietnam. Strengthening molecular surveillance, infection control and rational antibiotic use is essential to prevent the spread of multidrug-resistant pathogens.
    VL  - 11
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Sections